MedTrace Logo

Continuous Glucose Monitoring in High-Risk Children and Youth With Type 1 Diabetes in the Dominican Republic

NCT07742306 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-08-03

No results posted yet for this study

Summary

The goal of this pilot longitudinal study is to investigate whether intermittent use of the Dexcom G7 continuous glucose monitor, together with pediatric endocrinology follow-up, diabetes education, and psychological support, can improve glucose control in children and adolescents with high-risk type 1 diabetes in the Dominican Republic.

The study will include 40 participants, 10 to 19 years of age, from two pediatric diabetes care centers. Participants will use the Dexcom G7 during two short monitoring periods in the early part of the study. Each participant will use six sensors in total. Between and after these monitoring periods, participants will return to their usual finger-stick glucose monitoring with a glucometer. Participants and their families will also attend scheduled medical visits, diabetes education sessions, and psychological support sessions.

Study information will be collected from medical records, laboratory results, Dexcom Clarity reports, participant glucose logs, study forms, and questionnaires.

The study will assess changes in HbA1c, time in range, average glucose, glucose variability, low and high blood glucose episodes, adverse events, diabetes-related distress, fear of hypoglycemia, and satisfaction with glucose monitoring.

Conditions

  • Type 1 Diabetes (T1D)

Interventions

DEVICE

Intermittent CGM

Intermittent CGM + pediatric endocrinology follow-up, diabetes education and psychological support

Sponsors & Collaborators

  • Hospital Infantil Regional Universitario Dr. Arturo Grullón, Santiago de los Caballeros, Republica Dominican

    collaborator UNKNOWN

  • Pontificia Universidad Catolica Madre y Maestra (PUCMM), Santiago de Caballeros, Dominican Republic

    collaborator UNKNOWN

  • Instituto Tecnologico de Santo Domingo (INTEC) Santo Domingo, Dominican Republic

    collaborator UNKNOWN

  • Hospital Infantil Robert Reid Cabral, Santo Domingo, Dominican Republic

    collaborator UNKNOWN

  • Fundación Aprendiendo A Vivir, Santo Domingo, Dominican Republic

    collaborator UNKNOWN

  • Warren Alpert Medical School of Brown University, United States of America

    collaborator UNKNOWN

  • Life for a Child Program, Diabetes Australia

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-14
Primary Completion
2026-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • Dominican Republic

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07742306 on ClinicalTrials.gov